Autologous Exosomes · t-lab
EXOMINE.
Smart Kit
The next generation of regenerative medicine — powered by your own biology.
Physician controlledExosome-rich plasmaPatient-derived & safeClosed system
CE certified medical device
ISO 13485:2016
ISO 13485:2016
5.78TExosomes in 10 mL
30 minClosed-system preparation
≥89%Recovery
120 nmAverage exosome size (±15)
The science
What is an autologous exosome?
Exosomes are nanosized extracellular vesicles — about 30–150 nm — that cells use to exchange biochemical signals. They help injured tissues activate repair, regulate inflammation and restore normal function.
1
Autologous means the exosomes come from the patient's own blood — harvested from their own PRP. No donor material, no additives.
2
Rich molecular cargo — messenger RNA, microRNA and bioactive proteins that influence how recipient cells behave.
3
Exomine isolates and concentrates this exosome-rich fraction at the point of care, so it is prepared fresh for each patient.
Beyond conventional PRP
PRP delivers growth factors.
Exomine delivers regenerative instructions.
Conventional PRP
A regenerative stimulus
Concentrated autologous platelets in plasma, relying mainly on a temporary release of soluble growth factors.
Exomine
Cellular communication
A purified, concentrated exosome fraction that transfers regulatory microRNAs, proteins and signalling molecules directly to recipient cells — the evolution from growth-factor-based treatment to cellular communication-based regeneration.
Signal Amplification
Delivers complex intracellular instructions linked to cell proliferation, angiogenesis, collagen production and tissue regeneration.
Matrix Remodeling
Stimulates fibroblasts and supports balanced extracellular-matrix turnover for more organised collagen synthesis.
Immune Modulation
Influences macrophage polarisation and cytokine signalling, helping move healing from inflammation to repair.
Kit components
Two-step mechanical activation — no chemicals
MICROLYZER
Initial stimulation
- Over 3,500 microscopic blades with a 600 µm special design.
- Gently stretches the platelet's outer membrane to awaken its natural repair response.
- Preserves platelet viability — activation without destroying the platelets.
- No additives, no chemicals — 100% autologous.
PRX TUBE
Continuous stimulation
- Internal vertical lines create a vortex during centrifugation.
- Continuously stimulates platelets for enhanced exosome release into the plasma.
- Rich, complex cargo of molecules working in synergy.
- Non-immunogenic and biocompatible.
Technology & process
From blood draw to exosome-rich plasma
1
Obtain Blood
Collect blood and draw it into the PRX tube.
2
Collect PRP
Collect the upper plasma layer from each tube.
3
Platelet Activation
Pass plasma through the Microlyzer to initiate activation and exosome release.
4
Concentration
Transfer activated PRP into the Advanced Exosome Tube.
5
Final Centrifugation
Centrifuge sequentially to isolate the exosome-rich fraction.
A simple, closed-system process that delivers autologous exosome-enriched plasma in just 30 minutes — no special equipment required.
Quality & characterisation
Validated by flow cytometry & particle analysis
Exomine follows the MISEV2023 recommendations for extracellular vesicle characterisation and reporting.
5.78 trillionexosomes in 10 mL of final product
120 nm ±15average exosome size
CD9
99.6%Confirms exosome identity.
CD61
98.6%Confirms platelet-derived origin.
CD81
98.5%Confirms exosome purity.
CD41
99.4%Platelet-specific regenerative marker.
7-AAD
98.9%High preparation quality.
CD45
0.3%Minimal leukocyte contamination.
≥89%Recovery
5.5–6×Concentration
40 mLBlood volume
10 mLFinal volume
Compare exosome sources
Why autologous matters
| Topic | Autologous (Exomine) | Allogeneic human | Animal-based | Plant-based |
|---|---|---|---|---|
| Source | Patient's own blood — donor-free | Donor-derived human source | Non-human biological source | Plant-derived or exosome-like cosmetic source |
| Preparation | Point-of-care, physician-prepared, fresh | Manufactured under regulated laboratory controls | Off-the-shelf batch product | Off-the-shelf batch product |
| Regulation | Point-of-care medical device pathway; jurisdiction dependent | Use depends on product authorisation | Frequently positioned as cosmetic or topical | Typically cosmetic or topical |
| Delivery | Physician-directed point-of-care preparation | Use depends on product authorisation | Often topical; injectability depends on approval | Generally topical; not interchangeable with human EVs |
Clinical fields of application
One autologous platform, many specialities
Aesthetics
Dermatology & Aesthetic Medicine
Facial rejuvenation, scar remodelling and inflammatory skin conditions — supporting collagen and elastin synthesis for better tone, texture and elasticity.
Trichology
Hair Restoration
In androgenetic alopecia, supports dermal papilla activity and scalp vascularity; repeated sessions support visible density and thickness.
Wound care
Wound Healing
Supports fibroblast proliferation and keratinocyte migration in chronic or post-surgical wounds.
Orthopedics
Musculoskeletal Medicine
Tendinopathies, muscle tears, ligament injuries and early osteoarthritis.
Pain
Pain & Inflammatory Disorders
A biological approach acting on inflammatory mediators in chronic soft-tissue conditions.
Safety
Minimally Invasive
Simple venipuncture and local administration, derived exclusively from the patient's own plasma — no donor materials.
Bring Exomine to your clinic.
For healthcare professionals. Product information provided by the manufacturer. Distributed by Bionics Medical in the UAE and Saudi Arabia.